Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease

Am J Hematol. 2017 Sep;92(9):E561-E563. doi: 10.1002/ajh.24816. Epub 2017 Jul 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Chemokines, CC / blood
  • Child
  • Child, Preschool
  • Enzyme Replacement Therapy*
  • Erythrocyte Deformability / drug effects
  • Erythrocyte Membrane / chemistry
  • Erythrocyte Membrane / drug effects*
  • Female
  • Gaucher Disease / blood
  • Gaucher Disease / drug therapy*
  • Gaucher Disease / physiopathology
  • Glucosylceramidase / therapeutic use*
  • Hexosaminidases / blood
  • Humans
  • Male
  • Membrane Lipids / analysis
  • Middle Aged
  • Psychosine / analogs & derivatives
  • Psychosine / blood
  • Recombinant Proteins / therapeutic use
  • Young Adult

Substances

  • CCL18 protein, human
  • Chemokines, CC
  • Membrane Lipids
  • Recombinant Proteins
  • Psychosine
  • sphingosyl beta-glucoside
  • Hexosaminidases
  • chitotriosidase
  • Glucosylceramidase
  • Velaglucerase alfa, human